Biotinylated Human IL-18RAP/IL-18 R beta Protein
Catalog No: IL18-HB002
- Species
- Human
- Expression System
- HEK293
- Tag
- His, Avi
- Activity
- Activity verified
Product overview
Recombinant Biotinylated Human IL-18RAP/IL-18 R beta Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Phe20-Arg356 (UniProt accession: O95256-1).
Product Details
- Molecular Aliases
- IL-18 R beta; ACPL; CD218b; CDw218b; IL-18R-beta; IL-18RAcP; IL-18Rbeta; IL-1R-7; IL-1R7; IL-1RAcPL; IL18RB; IL18RAP; IL-18R-beta; IL-18R-β; IL-18Rβ;IL18R beta; IL18R-beta; IL18RAcP; IL18Rbeta; IL1R7; IL1RAcPL; IL18R-β; IL18Rβ;IL-18R-b; IL18R-b; IL-18Rb; IL-18R beta
- Protein Length
- Phe20-Arg356
- Expression System
- HEK293
- Theoretical Molecular Weight
- The protein has a predicted MW of 41.35 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
- Purity
- > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
- Endotoxin
- Less than 1 EU per μg by the LAL method.
- Buffer / Formulation
- Supplied as 0.22 μm filtered solution in PBS (pH 7.4).
- State
- Liquid
- Storage Conditions
- Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Data Display
Biotinylated Human IL-18RAP on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Biotinylated Human IL-18RAP is greater than 95% as determined by SEC-HPLC.
Immobilized Biotinylated Human IL-18 RAP, His Avi tag at 0.5μg/ml (100μl/well) on the streptavidin precoated plate (5μg/ml). Dose response curve for Anti-IL-18RAP Antibody, hFc Tag with the EC50 of 6.4ng/ml determined by ELISA.
Background
lactoferrin (LTF), peptidoglycan recognition protein 1 and IL-18 receptor accessory protein (IL-18RAP) remained significantly elevated in peripheral monocytes of hypertensive individuals in a separate validation cohort. Interestingly, IL18RAP expression associated with MAP in a cohort of African Americans..
References
- Hedl M, Zheng S, Abraham C. The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways. J Immunol. 2014;192(12):5924-5932. doi:10.4049/jimmunol.1302727
Have questions about this product?
Our technical team can help with product selection, application questions and order support.